Skip to content

Mark Clein, Co-Founder and CEO of Precision Medicine Group, delivers the keynote address for BioTrinity 2020

You can view his address at your convenience here. In the course of his presentation you will hear:

  • The ways in which digital technology is transforming patient care and impacting clinical trials
  • What new breakthroughs are on the horizon
  • How precision medicine continues to advance and affect patient treatment and outcomes